- Ph.D., Biomedical Engineering, Cornell University, 2019
- M.S., Biomedical Engineering, Cornell University, 2016
- B.S., Bioengineering, Oregon State University, 2013
- National Science Foundation Graduate Research Fellowship Program, Cornell University, 2015-2018
- Howard Hughes Medical Institute Med-Into-Grad Fellowship, Cornell University, 2014-2015
Dr. Daniel Cheung's expertise is in tissue engineering with specialization in cardiovascular tissue engineering and 3D printing/bioprintable biomaterials. He has expertise in characterizing cell phenotype and behavior within 3D hydrogel systems (including collagen, gelatin, hyaluronic acid, nanocellulose, and decellularized tissues) using histology, immunohistochemistry, gene expression, and western blotting.
Dr. Cheung is proficient in large animal tissue dissection and preparing specimen for uniaxial mechanical testing, cell isolation, and tissue culture. He also has experience in using SolidWorks, Autodesk Fusion 360, and 3D printers for rapid prototyping of custom bioreactors (strain, perfusion, and pulsatile) and coding in MATLAB, Python, R, and FIJI/ImageJ for data acquisition and analysis.
Prior to joining Exponent, Dr. Cheung completed his Ph.D. in Biomedical Engineering at Cornell University where he evaluated human mesenchymal stem cell behavior on tissue-derived biomaterials for fabricating tissue engineered heart valves. Specifically, he incorporated decellularized heart valve tissues or plant-derived components with methacrylated gelatin or methacrylated hyaluronic acid hydrogels to modulate cell phenotype. He also designed, built, and validated a bioreactor system to condition ex vivo and engineered heart valve tissues.